Every year, approximately 700 Canadians are diagnosed with chronic myeloid leukemia (CML), a type of blood cancer that starts in the bone marrow. While there is no cure, people with CML today have a ...
Single-cell analysis of CML patients bone marrow at diagnosis reveals coexistence of CD26-CD35+ healthy stem cells and CD26+CD35- CML stem cells, and how the ratio between these impacts TKI response.
Basel, October 29, 2024 – Novartis announced today that Scemblix ® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed ...
Ad hoc announcement pursuant to Art. 53 LR Scemblix, a new first-line option for adults with CML, is first to show superior efficacy and favorable safety and tolerability profile in a Phase III trial ...
Assam, has taken a significant step towards ensuring sustainable water supply for future generations by signing two Memorandum of Understandings (MoUs). The first MoU is with the Centre for ...
The trial aims to enrol NSCLC patients who have not responded to frontline platinum-based and immune checkpoint inhibitor therapies. Credit: New Africa/Shutterstock. Genelux has dosed the first ...
A technology-accepted model for assessing cryptocurrency mining performance is presented, along with an analysis of the impacts of high CML penetration on power grid planning and operation. Findings ...